Current Opinion in Rheumatology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Rheumatology is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
John Varga, MD, is the John and Nancy Hughes Distinguished Professor at Northwestern University's Feinberg School of Medicine in Chicago, Illinois, USA.
Dr Varga came to the United States as a refugee from Hungary. He received his undergraduate education at Columbia University in New York and received his medical degree from New York University, USA. Following a rheumatology fellowship in Boston, he pursued post-doctoral research training with Professor Sergio Jimenez at the University of Pennsylvania, USA. In 2004, he joined the faculty at Feinberg School of Medicine, USA, where he founded and directs the integrated Northwestern Scleroderma Program. His research focuses on the pathogenesis and treatment of scleroderma and fibrosis, and bridges clinical and laboratory-based investigation.
Dr Varga is the author of more than 350 original articles, 40 book chapters and four books. His research has been funded by the National Institutes of Health and the Scleroderma Research Foundation. He is an elected member of the Association of American Physicians, and is Master of the American College of Rheumatology.
Anna Ghirardello, DSc, PhD, graduated in biological sciences from the University of Padova, Italy, where she also qualified in clinical pathology. She received her PhD degree and post-doctoral fellowship at the University of Padova. She is Biologist at the University Hospital of Padova. Her main fields of interest include the pathogenesis and laboratory diagnostics of connective tissue diseases, focused primarily on systemic lupus erythematosus and idiopathic inflammatory myopathies. Dr Ghirardello is a member of the Italian Society of Rheumatology (SIR), council member of the Italian Interdisciplinary Forum for the Research in Autoimmune Diseases (FIRMA), and member of the EuroMyositis Registry. She has authored over 120 ISI publications.
Andrea Doria, MD, is Professor of Rheumatology and Head of the Unit of Connective Tissue Disease and Rare Rheumatic Diseases, Division of Rheumatology, Department of Medicine, University of Padua, Italy.
He received his medical degree and qualification in rheumatology from the University of Padua. He was council member of the Italian College of Rheumatology (CRO) between 1999 and 2005 and a council member of the Italian Society of Rheumatology (SIR) from 2007 to 2010 and from 2013 until now. He is also a member of American College of Rheumatology (ACR).
He has authored over 250 ISI publications on SLE and other connective tissue diseases. These include clinical studies describing new manifestations or subgroups of autoimmune disorders, prognostic risk factors, diagnostic tests and therapeutic interventions, as well as immunochemical studies that evaluate autoantibodies, epitopes and complementary epitopes of autoantigens. In addition, he has authored and co-authored three books, over 90 book chapters and conference proceedings, and over 500 abstracts for national and international conferences.
Professor Doria has long-standing experience of the clinical management of patients with connective tissue diseases. The unit in which he works is a tertiary referral rheumatology centre, within Italy, for the diagnosis and management of patients affected with systemic connective diseases. In addition, he has expertise in the management and follow-up of pregnant patients with systemic rheumatic diseases. Professor Doria has also trained over 30 students in rheumatology.